O'Malley DM, Oaknin A, Monk BJ, Selle F, et al. Phase II study of the safety and efficacy of the anti-PD-1 antibody balstilimab
in patients with recurrent and/or metastatic cervical cancer. Gynecol Oncol 2021 Aug 24. pii: S0090-8258(21)01316.
PMID: 34452745